- Home
- ASLE vs SNY Comparison
ASLE vs SNY Comparison
Compare ASLE & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASLE
- SNY
- Stock Information
- Founded
- ASLE 2008
- SNY 1994
- Country
- ASLE United States
- SNY France
- Employees
- ASLE N/A
- SNY N/A
- Industry
- ASLE Industrial Specialties
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- ASLE Consumer Discretionary
- SNY Health Care
- Exchange
- ASLE Nasdaq
- SNY Nasdaq
- Market Cap
- ASLE 400.6M
- SNY 113.4B
- IPO Year
- ASLE N/A
- SNY N/A
- Fundamental
- Price
- ASLE $8.33
- SNY $46.97
- Analyst Decision
- ASLE Hold
- SNY Buy
- Analyst Count
- ASLE 2
- SNY 4
- Target Price
- ASLE $7.00
- SNY $61.50
- AVG Volume (30 Days)
- ASLE 480.3K
- SNY 2.7M
- Earning Date
- ASLE 11-06-2025
- SNY 10-24-2025
- Dividend Yield
- ASLE N/A
- SNY 3.40%
- EPS Growth
- ASLE N/A
- SNY 118.56
- EPS
- ASLE 0.13
- SNY 8.65
- Revenue
- ASLE $350,583,000.00
- SNY $53,714,621,258.00
- Revenue This Year
- ASLE $9.98
- SNY $1.53
- Revenue Next Year
- ASLE $8.15
- SNY $7.06
- P/E Ratio
- ASLE $68.55
- SNY $5.43
- Revenue Growth
- ASLE N/A
- SNY 15.65
- 52 Week Low
- ASLE $4.53
- SNY $44.73
- 52 Week High
- ASLE $9.12
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- ASLE 50.70
- SNY 43.02
- Support Level
- ASLE $8.44
- SNY $46.50
- Resistance Level
- ASLE $8.92
- SNY $47.69
- Average True Range (ATR)
- ASLE 0.30
- SNY 0.68
- MACD
- ASLE -0.09
- SNY -0.18
- Stochastic Oscillator
- ASLE 22.08
- SNY 36.14
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.